|
|
|
|
|
|
|
|
Breast (101183)
Sponsor: NSABP (B-40)
|
By Breast on
7/2/2009 4:00 AM
|
|
|
A Randomized Phase III Trial of Neoadjuvant Therapy in Patients with
Palpable and Operable Breast Cancer Evaluating the Effect on
Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine toDocetaxel when Administered Before AC with or without Bevacizumab andCorrelative Science Studies Attempting to Identify Predictorsof High Likelihood for pCR with Each of the Regimens
Informed Consent
Protocol
|
 |
|
|
More...
|
|
|
|
|
|
|
Breast (101293)
Sponsor: NSABP (B-42)
|
By Breast on
7/2/2009 4:00 AM
|
|
|
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer
HIPAA Authorization
Informed Consent
Protocol
|
|
|
|
|
More...
|
|
|
|
|
|